Industrial Property Code News Today

Ruling on the condition of plausible proof, the Ankara IP Court has clarified that an injunction can be granted in a way that prevents damages for both parties. This is especially crucial for cases in which the infringing product is put on the market without waiting for an expert report.

Mutlu Yıldırım Köse, Baran Güney, and Su Yücel of Gün + Partners analyse recent court decisions in Turkey aimed at tackling the complex legal relationship between trade names and trademark infringement

Turkey is often singled out as one of the biggest sources of counterfeit goods, but the country is taking the problem seriously and trying to tackle it head on. WIPR reports.

IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.

In 2022, Italy further strengthened the protection of IP rights in terms of both the introduction of new regulatory tools available to companies and the dissemination of best practices in case law. This article outlines the main developments, including a new administrative trademark procedure, the Italian legislature's intervention on the patent linkage mechanism and various landmark cases that confirm the realistic approach of IP specialised divisions and the high level of effectiveness the...

IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.

As of 29 December 2022, it is possible to file an application with the Italian Patent and Trademark Office (UIBM) for a declaration of invalidity…

With 13 months to go, excitement is brewing around the long-awaited implementation of 2017 proposal for cancellation requests to be heard centrally at the Turkish Patent and Trademark Office instead of at the local level.

Patent owners in Italy may file a lawsuit against an alleged infringer and begin proceedings on the substance of the case…

This article examines the most consequential features of the IP and competition law frameworks in relation to the pharmaceutical sector in Portugal, with particular regard to recent developments.